You are here

Gilead Sceinces

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Wed, 04/26/23 - 05:50 pm

Bristol Myers Squibb

Gilead Sceinces